Radiation Therapy Equipment Vendors to Evaluate System Integration
|
By MedImaging International staff writers Posted on 17 Mar 2009 |
The goal of a new multi-year project is to reduce medical errors and improve efficiency by allowing physicians to purchase the best radiotherapy equipment for their practices, regardless of the manufacturer.
The American Society for Radiation Oncology (ASTRO) will host a "connection marathon” at its headquarters in Fairfax, VA, USA, in September 2009 as part of the Integrating the Healthcare Enterprise-Radiation Oncology (IHE-RO) initiative to promote seamless connectivity and integration of radiotherapy equipment, and patient health information systems, in a new project called a connectathon. This meeting will be the final step in a process that has included vendor development, software testing, and real-time interconnectivity testing.
"ASTRO is honored to be a leader of such a critical initiative as the IHE project,” said Laura I. Thevenot, ASTRO's chief executive officer. "By ensuring that vendors meet the IHE-RO integration requirements, we are enabling radiation oncology teams to better implement the advanced technology available to them and better communicate vital information to the men and women undergoing treatment for cancer. I congratulate all the vendors participating in this initiative that I believe will help lead to more seamless patient care.”
Allowing physicians to purchase the best equipment for their practices, regardless of manufacturer, will hopefully reduce medical errors, as healthcare staff will no longer have to reenter information because systems are unable to communicate. This will also allow equipment makers to focus on developing their niche systems rather than forcing them to produce an entire product line.
The upcoming event will be the third connectathon that ASTRO has organized as part of IHE-RO. The most recent event was held last summer in Houston, TX, USA, at the Proton Therapy Center located at M.D. Anderson Cancer Center. Participants were required to demonstrate their ability to accept information from at least three different vendors and have their information accepted by three different systems for various aspects of the treatment planning process. Two distinct workflows, known as profiles, were available for the vendors to test against as appropriate for their products and the roles, known as actors, their products play in the workflow.
The 2008 connectathon was very successful. All vendors achieved a passing mark for at least one of the roles their products play. This included passing the IHE-RO test suite, which involved computer software testing that the vendors submitted before the connectathon in order to confirm the base functionality of the products, and the IHE-RO connectathon testing, which was performed between manufacturers live during the connectathon, by proving that the applications they submitted for testing conformed to the particular IHE-RO integration profile. These vendors were invited to the IHE-RO public demonstration held at ASTRO's 50th annual meeting in Boston, MA, USA, in the fall of 2008.
IHE-RO is a branch of Integrating the Healthcare Enterprise project, which began in 2004 under the direction of the Healthcare Information Management Systems Society (Chicago, IL, USA) and the Radiological Society of North America (Oak Brook, IL, USA) as a way to improve the way that healthcare computer systems share information. IHE-RO involves the integration of radiotherapy equipment specifically and, when successfully implemented, provides for radiotherapy equipment produced by different vendors to work together and share information.
ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology, and physics, the Society is focused on improving patient care through education, clinical practice, advancement of science, and advocacy.
Related Links:
American Society for Radiation Oncology
The American Society for Radiation Oncology (ASTRO) will host a "connection marathon” at its headquarters in Fairfax, VA, USA, in September 2009 as part of the Integrating the Healthcare Enterprise-Radiation Oncology (IHE-RO) initiative to promote seamless connectivity and integration of radiotherapy equipment, and patient health information systems, in a new project called a connectathon. This meeting will be the final step in a process that has included vendor development, software testing, and real-time interconnectivity testing.
"ASTRO is honored to be a leader of such a critical initiative as the IHE project,” said Laura I. Thevenot, ASTRO's chief executive officer. "By ensuring that vendors meet the IHE-RO integration requirements, we are enabling radiation oncology teams to better implement the advanced technology available to them and better communicate vital information to the men and women undergoing treatment for cancer. I congratulate all the vendors participating in this initiative that I believe will help lead to more seamless patient care.”
Allowing physicians to purchase the best equipment for their practices, regardless of manufacturer, will hopefully reduce medical errors, as healthcare staff will no longer have to reenter information because systems are unable to communicate. This will also allow equipment makers to focus on developing their niche systems rather than forcing them to produce an entire product line.
The upcoming event will be the third connectathon that ASTRO has organized as part of IHE-RO. The most recent event was held last summer in Houston, TX, USA, at the Proton Therapy Center located at M.D. Anderson Cancer Center. Participants were required to demonstrate their ability to accept information from at least three different vendors and have their information accepted by three different systems for various aspects of the treatment planning process. Two distinct workflows, known as profiles, were available for the vendors to test against as appropriate for their products and the roles, known as actors, their products play in the workflow.
The 2008 connectathon was very successful. All vendors achieved a passing mark for at least one of the roles their products play. This included passing the IHE-RO test suite, which involved computer software testing that the vendors submitted before the connectathon in order to confirm the base functionality of the products, and the IHE-RO connectathon testing, which was performed between manufacturers live during the connectathon, by proving that the applications they submitted for testing conformed to the particular IHE-RO integration profile. These vendors were invited to the IHE-RO public demonstration held at ASTRO's 50th annual meeting in Boston, MA, USA, in the fall of 2008.
IHE-RO is a branch of Integrating the Healthcare Enterprise project, which began in 2004 under the direction of the Healthcare Information Management Systems Society (Chicago, IL, USA) and the Radiological Society of North America (Oak Brook, IL, USA) as a way to improve the way that healthcare computer systems share information. IHE-RO involves the integration of radiotherapy equipment specifically and, when successfully implemented, provides for radiotherapy equipment produced by different vendors to work together and share information.
ASTRO is the largest radiation oncology society in the world, with more than 10,000 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology, and physics, the Society is focused on improving patient care through education, clinical practice, advancement of science, and advocacy.
Related Links:
American Society for Radiation Oncology
Latest Nuclear Medicine News
- PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
- Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
- New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
- PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers
- New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis
- Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections
- New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
Channels
MRI
view channel
Novel Imaging Approach to Improve Treatment for Spinal Cord Injuries
Vascular dysfunction in the spinal cord contributes to multiple neurological conditions, including traumatic injuries and degenerative cervical myelopathy, where reduced blood flow can lead to progressive... Read more
AI-Assisted Model Enhances MRI Heart Scans
A cardiac MRI can reveal critical information about the heart’s function and any abnormalities, but traditional scans take 30 to 90 minutes and often suffer from poor image quality due to patient movement.... Read more
AI Model Outperforms Doctors at Identifying Patients Most At-Risk of Cardiac Arrest
Hypertrophic cardiomyopathy is one of the most common inherited heart conditions and a leading cause of sudden cardiac death in young individuals and athletes. While many patients live normal lives, some... Read moreUltrasound
view channel
Wearable Ultrasound Imaging System to Enable Real-Time Disease Monitoring
Chronic conditions such as hypertension and heart failure require close monitoring, yet today’s ultrasound imaging is largely confined to hospitals and short, episodic scans. This reactive model limits... Read more
Ultrasound Technique Visualizes Deep Blood Vessels in 3D Without Contrast Agents
Producing clear 3D images of deep blood vessels has long been difficult without relying on contrast agents, CT scans, or MRI. Standard ultrasound typically provides only 2D cross-sections, limiting clinicians’... Read moreNuclear Medicine
view channel
PET Imaging of Inflammation Predicts Recovery and Guides Therapy After Heart Attack
Acute myocardial infarction can trigger lasting heart damage, yet clinicians still lack reliable tools to identify which patients will regain function and which may develop heart failure.... Read more
Radiotheranostic Approach Detects, Kills and Reprograms Aggressive Cancers
Aggressive cancers such as osteosarcoma and glioblastoma often resist standard therapies, thrive in hostile tumor environments, and recur despite surgery, radiation, or chemotherapy. These tumors also... Read more
New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer
Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read moreGeneral/Advanced Imaging
view channel
3D Scanning Approach Enables Ultra-Precise Brain Surgery
Precise navigation is critical in neurosurgery, yet even small alignment errors can affect outcomes when operating deep within the brain. A new 3D surface-scanning approach now provides a radiation-free... Read more
AI Tool Improves Medical Imaging Process by 90%
Accurately labeling different regions within medical scans, a process known as medical image segmentation, is critical for diagnosis, surgery planning, and research. Traditionally, this has been a manual... Read more
New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more
AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
In pancreatic cancer, detecting whether the disease has spread to other organs is critical for determining whether surgery is appropriate. If metastasis is present, surgery is not recommended, yet current... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read morePatient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more







